

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 6.28650127 |
| 2 | macroautophagy (GO:0016236) | 4.53864518 |
| 3 | response to pheromone (GO:0019236) | 4.34311591 |
| 4 | retinal rod cell development (GO:0046548) | 3.96076959 |
| 5 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.93896252 |
| 6 | mannose metabolic process (GO:0006013) | 3.82093756 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.74448874 |
| 8 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.74190995 |
| 9 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.61887621 |
| 10 | phosphatidylglycerol biosynthetic process (GO:0006655) | 3.58600637 |
| 11 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.57139230 |
| 12 | positive regulation of B cell differentiation (GO:0045579) | 3.45195439 |
| 13 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.37538554 |
| 14 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.37119852 |
| 15 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.35595905 |
| 16 | modulation by symbiont of host immune response (GO:0052553) | 3.35595905 |
| 17 | positive regulation by symbiont of host defense response (GO:0052509) | 3.35595905 |
| 18 | modulation by symbiont of host defense response (GO:0052031) | 3.35595905 |
| 19 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.35595905 |
| 20 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.35595905 |
| 21 | macrophage activation involved in immune response (GO:0002281) | 3.24160667 |
| 22 | regulation of cholesterol homeostasis (GO:2000188) | 3.20953336 |
| 23 | sodium ion export (GO:0071436) | 3.18310807 |
| 24 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.17743681 |
| 25 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.13437751 |
| 26 | detection of light stimulus involved in visual perception (GO:0050908) | 3.07389260 |
| 27 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.07389260 |
| 28 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 3.04410968 |
| 29 | valine metabolic process (GO:0006573) | 3.03113580 |
| 30 | positive regulation of histone deacetylation (GO:0031065) | 3.02845847 |
| 31 | negative regulation of mast cell activation (GO:0033004) | 2.95975876 |
| 32 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.94653529 |
| 33 | negative regulation of bone resorption (GO:0045779) | 2.90951136 |
| 34 | positive regulation of p38MAPK cascade (GO:1900745) | 2.90560651 |
| 35 | 2-oxoglutarate metabolic process (GO:0006103) | 2.88826912 |
| 36 | negative regulation of granulocyte differentiation (GO:0030853) | 2.85477802 |
| 37 | creatine metabolic process (GO:0006600) | 2.85117642 |
| 38 | positive regulation of fatty acid oxidation (GO:0046321) | 2.81842361 |
| 39 | tricarboxylic acid metabolic process (GO:0072350) | 2.81565954 |
| 40 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.79989739 |
| 41 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.69773496 |
| 42 | response to host (GO:0075136) | 2.69773496 |
| 43 | response to host defenses (GO:0052200) | 2.69773496 |
| 44 | phospholipid homeostasis (GO:0055091) | 2.69493602 |
| 45 | cellular potassium ion homeostasis (GO:0030007) | 2.69223711 |
| 46 | apoptotic cell clearance (GO:0043277) | 2.66108328 |
| 47 | growth hormone receptor signaling pathway (GO:0060396) | 2.65755002 |
| 48 | COPI coating of Golgi vesicle (GO:0048205) | 2.65469491 |
| 49 | Golgi transport vesicle coating (GO:0048200) | 2.65469491 |
| 50 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.64765563 |
| 51 | microglial cell activation (GO:0001774) | 2.63134178 |
| 52 | response to methylmercury (GO:0051597) | 2.62490018 |
| 53 | response to host immune response (GO:0052572) | 2.62168976 |
| 54 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.62168976 |
| 55 | DNA deamination (GO:0045006) | 2.61358587 |
| 56 | myelination in peripheral nervous system (GO:0022011) | 2.61322286 |
| 57 | peripheral nervous system axon ensheathment (GO:0032292) | 2.61322286 |
| 58 | regulation of tight junction assembly (GO:2000810) | 2.61304218 |
| 59 | cellular response to ATP (GO:0071318) | 2.61114507 |
| 60 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.60705042 |
| 61 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.60079998 |
| 62 | prostate gland growth (GO:0060736) | 2.59203749 |
| 63 | protein kinase C signaling (GO:0070528) | 2.58196556 |
| 64 | regulation of cholesterol storage (GO:0010885) | 2.57173744 |
| 65 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.55788282 |
| 66 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.55628671 |
| 67 | alpha-linolenic acid metabolic process (GO:0036109) | 2.54722141 |
| 68 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.53949398 |
| 69 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.53866387 |
| 70 | pentose-phosphate shunt (GO:0006098) | 2.53855563 |
| 71 | 4-hydroxyproline metabolic process (GO:0019471) | 2.53425099 |
| 72 | protein-lipid complex assembly (GO:0065005) | 2.52596108 |
| 73 | fatty acid homeostasis (GO:0055089) | 2.50931224 |
| 74 | response to lipoprotein particle (GO:0055094) | 2.50644589 |
| 75 | regulation of ARF protein signal transduction (GO:0032012) | 2.49375696 |
| 76 | lytic vacuole organization (GO:0080171) | 2.48428881 |
| 77 | lysosome organization (GO:0007040) | 2.48428881 |
| 78 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.48050467 |
| 79 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.48006031 |
| 80 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.48006031 |
| 81 | response to laminar fluid shear stress (GO:0034616) | 2.47830755 |
| 82 | cellular response to exogenous dsRNA (GO:0071360) | 2.45600647 |
| 83 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.41335220 |
| 84 | negative regulation of cell killing (GO:0031342) | 2.41335220 |
| 85 | alanine transport (GO:0032328) | 2.41134558 |
| 86 | basic amino acid transport (GO:0015802) | 2.41112208 |
| 87 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.36926221 |
| 88 | immunoglobulin mediated immune response (GO:0016064) | 2.36763741 |
| 89 | potassium ion import (GO:0010107) | 2.36294460 |
| 90 | regulation of p38MAPK cascade (GO:1900744) | 2.36280796 |
| 91 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.35526472 |
| 92 | positive regulation of nuclease activity (GO:0032075) | 2.35385655 |
| 93 | glycogen catabolic process (GO:0005980) | 2.33895463 |
| 94 | germinal center formation (GO:0002467) | 2.33732378 |
| 95 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.33209685 |
| 96 | eye photoreceptor cell development (GO:0042462) | 2.31718894 |
| 97 | regulation of sequestering of triglyceride (GO:0010889) | 2.31308902 |
| 98 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.30722777 |
| 99 | photoreceptor cell development (GO:0042461) | 2.30125238 |
| 100 | photoreceptor cell maintenance (GO:0045494) | 2.30043289 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.28794677 |
| 102 | negative regulation of tissue remodeling (GO:0034104) | 2.28368451 |
| 103 | cellular response to growth hormone stimulus (GO:0071378) | 2.28213069 |
| 104 | adaptation of signaling pathway (GO:0023058) | 2.27721018 |
| 105 | toxin transport (GO:1901998) | 2.27567188 |
| 106 | regulation of gamma-delta T cell activation (GO:0046643) | 2.26324599 |
| 107 | positive regulation of cholesterol efflux (GO:0010875) | 2.25706377 |
| 108 | I-kappaB phosphorylation (GO:0007252) | 2.25225578 |
| 109 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.24060222 |
| 110 | * negative regulation of TOR signaling (GO:0032007) | 2.22451357 |
| 111 | keratan sulfate catabolic process (GO:0042340) | 2.20179416 |
| 112 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.20112579 |
| 113 | negative regulation of bone remodeling (GO:0046851) | 2.20034572 |
| 114 | carnitine shuttle (GO:0006853) | 2.19577033 |
| 115 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.19218069 |
| 116 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.18601175 |
| 117 | negative regulation of lipid transport (GO:0032369) | 2.18534677 |
| 118 | phosphatidylethanolamine biosynthetic process (GO:0006646) | 2.18516768 |
| 119 | cellular response to unfolded protein (GO:0034620) | 2.18334596 |
| 120 | ER-nucleus signaling pathway (GO:0006984) | 2.17440937 |
| 121 | cellular polysaccharide catabolic process (GO:0044247) | 2.16466634 |
| 122 | amyloid precursor protein catabolic process (GO:0042987) | 2.15956632 |
| 123 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.15635644 |
| 124 | negative regulation of type 2 immune response (GO:0002829) | 2.13068336 |
| 125 | neuromuscular process controlling posture (GO:0050884) | 2.12871871 |
| 126 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.11402260 |
| 127 | tryptophan catabolic process (GO:0006569) | 2.08621879 |
| 128 | indole-containing compound catabolic process (GO:0042436) | 2.08621879 |
| 129 | indolalkylamine catabolic process (GO:0046218) | 2.08621879 |
| 130 | white fat cell differentiation (GO:0050872) | 2.07440364 |
| 131 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.07009485 |
| 132 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.04020913 |
| 133 | regulation of mast cell activation (GO:0033003) | 2.01513196 |
| 134 | protein localization to endosome (GO:0036010) | 2.01210357 |
| 135 | membrane depolarization during action potential (GO:0086010) | 2.00847873 |
| 136 | regulation of germinal center formation (GO:0002634) | 2.00468898 |
| 137 | positive regulation of alcohol biosynthetic process (GO:1902932) | 1.99550052 |
| 138 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 1.97995151 |
| 139 | regulation of beta-amyloid formation (GO:1902003) | 1.96586925 |
| 140 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 1.95247182 |
| 141 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 1.95247182 |
| 142 | negative regulation of innate immune response (GO:0045824) | 1.94147160 |
| 143 | synaptic vesicle maturation (GO:0016188) | 1.92888614 |
| 144 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 1.92853760 |
| 145 | negative regulation of lipid storage (GO:0010888) | 1.90817024 |
| 146 | regulation of fatty acid oxidation (GO:0046320) | 1.88652282 |
| 147 | N-acetylneuraminate metabolic process (GO:0006054) | 1.88501050 |
| 148 | response to pH (GO:0009268) | 1.87129111 |
| 149 | striated muscle atrophy (GO:0014891) | 1.85851392 |
| 150 | positive regulation of defense response to virus by host (GO:0002230) | 1.85663217 |
| 151 | regulation of triglyceride biosynthetic process (GO:0010866) | 1.85280925 |
| 152 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 1.85193075 |
| 153 | positive regulation of Rap GTPase activity (GO:0032854) | 1.84152199 |
| 154 | cell differentiation involved in embryonic placenta development (GO:0060706) | 1.83936899 |
| 155 | interferon-gamma secretion (GO:0072643) | 1.83154054 |
| 156 | negative regulation of interleukin-1 production (GO:0032692) | 1.82976352 |
| 157 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 1.82684256 |
| 158 | chondroitin sulfate catabolic process (GO:0030207) | 1.82558376 |
| 159 | T cell lineage commitment (GO:0002360) | 1.82146178 |
| 160 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 1.81935818 |
| 161 | kynurenine metabolic process (GO:0070189) | 1.81652885 |
| 162 | regulation of membrane repolarization (GO:0060306) | 1.81576031 |
| 163 | vesicle transport along microtubule (GO:0047496) | 1.81068468 |
| 164 | regulation of action potential (GO:0098900) | 1.80926542 |
| 165 | positive regulation of fatty acid transport (GO:2000193) | 1.80805084 |
| 166 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 1.80479878 |
| 167 | cellular response to ethanol (GO:0071361) | 1.80404386 |
| 168 | negative regulation of T-helper cell differentiation (GO:0045623) | 1.80237601 |
| 169 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 1.80237601 |
| 170 | proline transport (GO:0015824) | 1.80103890 |
| 171 | preassembly of GPI anchor in ER membrane (GO:0016254) | 1.79834689 |
| 172 | negative regulation of interleukin-12 production (GO:0032695) | 1.78655573 |
| 173 | gland morphogenesis (GO:0022612) | 1.78355122 |
| 174 | mitochondrion degradation (GO:0000422) | 1.77443101 |
| 175 | amino sugar catabolic process (GO:0046348) | 1.76464589 |
| 176 | negative regulation of protein oligomerization (GO:0032460) | 1.74362634 |
| 177 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 1.74259660 |
| 178 | positive regulation of protein deacetylation (GO:0090312) | 1.73809502 |
| 179 | NAD biosynthetic process (GO:0009435) | 1.73458261 |
| 180 | regulation of cAMP-mediated signaling (GO:0043949) | 1.73093429 |
| 181 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.73010701 |
| 182 | urinary tract smooth muscle contraction (GO:0014848) | 1.72982990 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | GATA1_22025678_ChIP-Seq_K562_Human | 2.81818784 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.81493681 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.79396895 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.74857372 |
| 5 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.56863652 |
| 6 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.54981650 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.50154510 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.42835220 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.39328918 |
| 10 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37132498 |
| 11 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36714321 |
| 12 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.32089762 |
| 13 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.29937546 |
| 14 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.21194269 |
| 15 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15666407 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.15481149 |
| 17 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.14604256 |
| 18 | MYC_22102868_ChIP-Seq_BL_Human | 2.13373073 |
| 19 | SPI1_23127762_ChIP-Seq_K562_Human | 2.12523211 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.11044446 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.09544656 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05089198 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03399142 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.00942297 |
| 25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.00337059 |
| 26 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.96526170 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.91560864 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86561444 |
| 29 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.85275852 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.84026949 |
| 31 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.81469630 |
| 32 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.81087938 |
| 33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.80093036 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.79716777 |
| 35 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.79643606 |
| 36 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.79443562 |
| 37 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75363383 |
| 38 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.73305943 |
| 39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.72841377 |
| 40 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.72460300 |
| 41 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.71170628 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.69618121 |
| 43 | GATA1_19941826_ChIP-Seq_K562_Human | 1.66908297 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.66518356 |
| 45 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64348388 |
| 46 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.63882703 |
| 47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63115336 |
| 48 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.61625709 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.60110820 |
| 50 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56426095 |
| 51 | * STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.52227799 |
| 52 | MAF_26560356_Chip-Seq_TH1_Human | 1.49684110 |
| 53 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.45716454 |
| 54 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.45460456 |
| 55 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.44314472 |
| 56 | UTX_26944678_Chip-Seq_JUKART_Human | 1.43725502 |
| 57 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.41195640 |
| 58 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.40179463 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.40061499 |
| 60 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.36265281 |
| 61 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.36248072 |
| 62 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.34724070 |
| 63 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33361341 |
| 64 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.31125339 |
| 65 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.30881958 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.30120748 |
| 67 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.27863279 |
| 68 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.27695280 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27063685 |
| 70 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.26567232 |
| 71 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.24593474 |
| 72 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.23184118 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.23156024 |
| 74 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22776403 |
| 75 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.22568381 |
| 76 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.22568381 |
| 77 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.21656506 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21402765 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.20832136 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.20809898 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.20393447 |
| 82 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20322242 |
| 83 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.19113774 |
| 84 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.17696600 |
| 85 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.17390496 |
| 86 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.16252910 |
| 87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.15446160 |
| 88 | MYB_26560356_Chip-Seq_TH1_Human | 1.15429693 |
| 89 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.15164421 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14991625 |
| 91 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.14922545 |
| 92 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.14689674 |
| 93 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12413946 |
| 94 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.12375590 |
| 95 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.12374014 |
| 96 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11723776 |
| 97 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.11304915 |
| 98 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10011371 |
| 99 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.08848875 |
| 100 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.07929352 |
| 101 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.07453372 |
| 102 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.06172186 |
| 103 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.05414909 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.04082179 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04025428 |
| 106 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.03499289 |
| 107 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03032807 |
| 108 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03015052 |
| 109 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.02713734 |
| 110 | * P68_20966046_ChIP-Seq_HELA_Human | 1.02359427 |
| 111 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.01911084 |
| 112 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00812064 |
| 113 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.00122793 |
| 114 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.00093798 |
| 115 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.99949122 |
| 116 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.99174866 |
| 117 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99130023 |
| 118 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99128220 |
| 119 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98800105 |
| 120 | KDM2B_26808549_Chip-Seq_K562_Human | 0.98405831 |
| 121 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97859958 |
| 122 | MYB_26560356_Chip-Seq_TH2_Human | 0.97697173 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.97123295 |
| 124 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96942228 |
| 125 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.96938613 |
| 126 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96902993 |
| 127 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.96325232 |
| 128 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.96227680 |
| 129 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.95813170 |
| 130 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95677213 |
| 131 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95569562 |
| 132 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95447144 |
| 133 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.95416593 |
| 134 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.95416593 |
| 135 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.95017474 |
| 136 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.94856458 |
| 137 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.94402928 |
| 138 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.94372804 |
| 139 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91150775 |
| 140 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.90644342 |
| 141 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.90090378 |
| 142 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89485440 |
| 143 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.89309788 |
| 144 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.87947819 |
| 145 | * VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.84577422 |
| 146 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.83581242 |
| 147 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.82618146 |
| 148 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.81928223 |
| 149 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.81361367 |
| 150 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.79998490 |
| 151 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.78281830 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009840_abnormal_foam_cell | 4.28022361 |
| 2 | MP0005058_abnormal_lysosome_morphology | 4.01241648 |
| 3 | MP0003172_abnormal_lysosome_physiology | 3.66106050 |
| 4 | MP0003724_increased_susceptibility_to | 3.07976606 |
| 5 | MP0005670_abnormal_white_adipose | 2.74010083 |
| 6 | MP0003191_abnormal_cellular_cholesterol | 2.67430083 |
| 7 | MP0005551_abnormal_eye_electrophysiolog | 2.59383628 |
| 8 | MP0000604_amyloidosis | 2.16747030 |
| 9 | MP0005167_abnormal_blood-brain_barrier | 2.12833533 |
| 10 | MP0006072_abnormal_retinal_apoptosis | 2.05192461 |
| 11 | MP0002090_abnormal_vision | 2.00202168 |
| 12 | MP0003879_abnormal_hair_cell | 1.97692842 |
| 13 | MP0003011_delayed_dark_adaptation | 1.96626750 |
| 14 | MP0004036_abnormal_muscle_relaxation | 1.95313416 |
| 15 | MP0003950_abnormal_plasma_membrane | 1.92464679 |
| 16 | MP0005253_abnormal_eye_physiology | 1.89079002 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 1.86878430 |
| 18 | MP0004130_abnormal_muscle_cell | 1.85724496 |
| 19 | MP0002837_dystrophic_cardiac_calcinosis | 1.81892143 |
| 20 | MP0004084_abnormal_cardiac_muscle | 1.78302009 |
| 21 | MP0003045_fibrosis | 1.78283432 |
| 22 | MP0001485_abnormal_pinna_reflex | 1.77646698 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.77645845 |
| 24 | MP0004147_increased_porphyrin_level | 1.76802856 |
| 25 | MP0002064_seizures | 1.71702844 |
| 26 | MP0002876_abnormal_thyroid_physiology | 1.68575123 |
| 27 | MP0004510_myositis | 1.68396355 |
| 28 | MP0002638_abnormal_pupillary_reflex | 1.67706027 |
| 29 | MP0003690_abnormal_glial_cell | 1.65765973 |
| 30 | MP0004145_abnormal_muscle_electrophysio | 1.65688939 |
| 31 | MP0003329_amyloid_beta_deposits | 1.65262321 |
| 32 | MP0001501_abnormal_sleep_pattern | 1.64564844 |
| 33 | MP0001849_ear_inflammation | 1.64378100 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.61943789 |
| 35 | MP0002269_muscular_atrophy | 1.59489856 |
| 36 | MP0003436_decreased_susceptibility_to | 1.56126968 |
| 37 | MP0005365_abnormal_bile_salt | 1.55001299 |
| 38 | MP0009046_muscle_twitch | 1.54065236 |
| 39 | MP0009785_altered_susceptibility_to | 1.51983206 |
| 40 | MP0003183_abnormal_peptide_metabolism | 1.50771241 |
| 41 | MP0006082_CNS_inflammation | 1.48297057 |
| 42 | MP0004043_abnormal_pH_regulation | 1.48262434 |
| 43 | MP0003279_aneurysm | 1.48128617 |
| 44 | MP0002877_abnormal_melanocyte_morpholog | 1.44795673 |
| 45 | MP0002419_abnormal_innate_immunity | 1.42818853 |
| 46 | MP0004858_abnormal_nervous_system | 1.42474137 |
| 47 | MP0001324_abnormal_eye_pigmentation | 1.40528733 |
| 48 | MP0003656_abnormal_erythrocyte_physiolo | 1.39545959 |
| 49 | MP0004859_abnormal_synaptic_plasticity | 1.39449597 |
| 50 | MP0000749_muscle_degeneration | 1.39427934 |
| 51 | MP0001835_abnormal_antigen_presentation | 1.38235819 |
| 52 | MP0000685_abnormal_immune_system | 1.37428450 |
| 53 | MP0009764_decreased_sensitivity_to | 1.37291347 |
| 54 | MP0002148_abnormal_hypersensitivity_rea | 1.36126173 |
| 55 | MP0000569_abnormal_digit_pigmentation | 1.35488398 |
| 56 | MP0003635_abnormal_synaptic_transmissio | 1.33572217 |
| 57 | MP0009745_abnormal_behavioral_response | 1.31537372 |
| 58 | MP0000747_muscle_weakness | 1.31110840 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.31043731 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.29037530 |
| 61 | MP0002653_abnormal_ependyma_morphology | 1.28177070 |
| 62 | MP0003646_muscle_fatigue | 1.27838211 |
| 63 | MP0005646_abnormal_pituitary_gland | 1.26966627 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.26666182 |
| 65 | MP0000015_abnormal_ear_pigmentation | 1.26427209 |
| 66 | MP0002998_abnormal_bone_remodeling | 1.25295958 |
| 67 | MP0010329_abnormal_lipoprotein_level | 1.23703420 |
| 68 | MP0005367_renal/urinary_system_phenotyp | 1.23582938 |
| 69 | MP0000516_abnormal_urinary_system | 1.23582938 |
| 70 | MP0000609_abnormal_liver_physiology | 1.21678013 |
| 71 | MP0004947_skin_inflammation | 1.20654443 |
| 72 | MP0002063_abnormal_learning/memory/cond | 1.17803202 |
| 73 | MP0003303_peritoneal_inflammation | 1.16381048 |
| 74 | MP0005310_abnormal_salivary_gland | 1.15782817 |
| 75 | MP0002118_abnormal_lipid_homeostasis | 1.14082100 |
| 76 | MP0008872_abnormal_physiological_respon | 1.13884514 |
| 77 | MP0003633_abnormal_nervous_system | 1.13373953 |
| 78 | MP0000751_myopathy | 1.11775883 |
| 79 | MP0009384_cardiac_valve_regurgitation | 1.10752794 |
| 80 | MP0004087_abnormal_muscle_fiber | 1.10127075 |
| 81 | MP0004233_abnormal_muscle_weight | 1.10033870 |
| 82 | MP0004185_abnormal_adipocyte_glucose | 1.09941153 |
| 83 | MP0003195_calcinosis | 1.09282489 |
| 84 | MP0001440_abnormal_grooming_behavior | 1.08376397 |
| 85 | MP0000371_diluted_coat_color | 1.07007196 |
| 86 | MP0005195_abnormal_posterior_eye | 1.05489708 |
| 87 | MP0002971_abnormal_brown_adipose | 1.05130855 |
| 88 | MP0002272_abnormal_nervous_system | 1.04899590 |
| 89 | MP0003075_altered_response_to | 1.04739254 |
| 90 | MP0004885_abnormal_endolymph | 1.04053222 |
| 91 | MP0002078_abnormal_glucose_homeostasis | 1.03472688 |
| 92 | MP0002452_abnormal_antigen_presenting | 1.03287972 |
| 93 | MP0005387_immune_system_phenotype | 1.03141264 |
| 94 | MP0001790_abnormal_immune_system | 1.03141264 |
| 95 | MP0002909_abnormal_adrenal_gland | 1.02203991 |
| 96 | MP0001800_abnormal_humoral_immune | 1.02070125 |
| 97 | MP0002332_abnormal_exercise_endurance | 1.01830735 |
| 98 | MP0002139_abnormal_hepatobiliary_system | 1.01671548 |
| 99 | MP0002229_neurodegeneration | 1.01603081 |
| 100 | MP0003252_abnormal_bile_duct | 1.01112505 |
| 101 | MP0005671_abnormal_response_to | 1.00002704 |
| 102 | MP0009278_abnormal_bone_marrow | 0.99377125 |
| 103 | MP0003300_gastrointestinal_ulcer | 0.98872757 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.98732596 |
| 105 | MP0004270_analgesia | 0.98443660 |
| 106 | MP0005083_abnormal_biliary_tract | 0.97814475 |
| 107 | MP0001986_abnormal_taste_sensitivity | 0.96358485 |
| 108 | MP0001533_abnormal_skeleton_physiology | 0.96173401 |
| 109 | MP0010630_abnormal_cardiac_muscle | 0.96062916 |
| 110 | MP0005174_abnormal_tail_pigmentation | 0.95978949 |
| 111 | MP0005330_cardiomyopathy | 0.95038143 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.94915972 |
| 113 | MP0001765_abnormal_ion_homeostasis | 0.94488727 |
| 114 | MP0002572_abnormal_emotion/affect_behav | 0.94081978 |
| 115 | MP0003634_abnormal_glial_cell | 0.94061845 |
| 116 | MP0000343_altered_response_to | 0.93758546 |
| 117 | MP0002723_abnormal_immune_serum | 0.93690921 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.92359893 |
| 119 | MP0005000_abnormal_immune_tolerance | 0.90089771 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.89995004 |
| 121 | MP0000920_abnormal_myelination | 0.88857371 |
| 122 | MP0000230_abnormal_systemic_arterial | 0.88797196 |
| 123 | MP0002693_abnormal_pancreas_physiology | 0.86511277 |
| 124 | MP0002089_abnormal_postnatal_growth/wei | 0.85932925 |
| 125 | MP0001756_abnormal_urination | 0.85721480 |
| 126 | MP0003283_abnormal_digestive_organ | 0.84761600 |
| 127 | MP0005451_abnormal_body_composition | 0.84248154 |
| 128 | MP0001958_emphysema | 0.83839891 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.83828967 |
| 130 | MP0003631_nervous_system_phenotype | 0.83378006 |
| 131 | MP0008469_abnormal_protein_level | 0.82130157 |
| 132 | MP0002396_abnormal_hematopoietic_system | 0.81673010 |
| 133 | MP0005319_abnormal_enzyme/_coenzyme | 0.80862686 |
| 134 | MP0000689_abnormal_spleen_morphology | 0.80485862 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.80390523 |
| 136 | MP0002420_abnormal_adaptive_immunity | 0.79725726 |
| 137 | MP0001970_abnormal_pain_threshold | 0.79389433 |
| 138 | MP0002405_respiratory_system_inflammati | 0.79376498 |
| 139 | MP0005025_abnormal_response_to | 0.79045546 |
| 140 | MP0002106_abnormal_muscle_physiology | 0.78535215 |
| 141 | MP0005391_vision/eye_phenotype | 0.78290877 |
| 142 | MP0004484_altered_response_of | 0.78062612 |
| 143 | MP0002933_joint_inflammation | 0.77985029 |
| 144 | MP0005334_abnormal_fat_pad | 0.77911187 |
| 145 | MP0001819_abnormal_immune_cell | 0.77880857 |
| 146 | MP0009763_increased_sensitivity_to | 0.77310473 |
| 147 | MP0001853_heart_inflammation | 0.76220739 |
| 148 | MP0001968_abnormal_touch/_nociception | 0.76031033 |
| 149 | MP0001915_intracranial_hemorrhage | 0.75603404 |
| 150 | MP0005076_abnormal_cell_differentiation | 0.75284275 |
| 151 | MP0003566_abnormal_cell_adhesion | 0.75044166 |
| 152 | MP0005257_abnormal_intraocular_pressure | 0.74835522 |
| 153 | MP0000013_abnormal_adipose_tissue | 0.74335280 |
| 154 | MP0001845_abnormal_inflammatory_respons | 0.74261045 |
| 155 | MP0005085_abnormal_gallbladder_physiolo | 0.74161233 |
| 156 | MP0002127_abnormal_cardiovascular_syste | 0.74159915 |
| 157 | MP0002254_reproductive_system_inflammat | 0.73406486 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased cerebral lipofuscin (HP:0011813) | 5.22486564 |
| 2 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.92923850 |
| 3 | Congenital stationary night blindness (HP:0007642) | 4.74459050 |
| 4 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 4.28261224 |
| 5 | Short 1st metacarpal (HP:0010034) | 4.28261224 |
| 6 | Central scotoma (HP:0000603) | 4.27890071 |
| 7 | Dysostosis multiplex (HP:0000943) | 4.09562679 |
| 8 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 4.02481362 |
| 9 | Asymmetric septal hypertrophy (HP:0001670) | 3.76347085 |
| 10 | Abnormality of the 1st metacarpal (HP:0010009) | 3.70224271 |
| 11 | Abnormality of glycolipid metabolism (HP:0010969) | 3.62131082 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.62131082 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.62131082 |
| 14 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.60580135 |
| 15 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.60580135 |
| 16 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.60580135 |
| 17 | Neurofibrillary tangles (HP:0002185) | 3.59084522 |
| 18 | Mucopolysacchariduria (HP:0008155) | 3.55290779 |
| 19 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.55290779 |
| 20 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.51396472 |
| 21 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.50065104 |
| 22 | Abnormality of macular pigmentation (HP:0008002) | 3.40747480 |
| 23 | Scotoma (HP:0000575) | 3.30792601 |
| 24 | Hematochezia (HP:0002573) | 3.16627153 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.05161072 |
| 26 | Ectopic kidney (HP:0000086) | 2.97575599 |
| 27 | Abnormality of the renal collecting system (HP:0004742) | 2.93163906 |
| 28 | Progressive visual loss (HP:0000529) | 2.88399782 |
| 29 | Congenital sensorineural hearing impairment (HP:0008527) | 2.87368315 |
| 30 | Duplicated collecting system (HP:0000081) | 2.82982969 |
| 31 | Exercise-induced myalgia (HP:0003738) | 2.81863042 |
| 32 | Genetic anticipation (HP:0003743) | 2.81643766 |
| 33 | Diplopia (HP:0000651) | 2.78357832 |
| 34 | Abnormality of binocular vision (HP:0011514) | 2.78357832 |
| 35 | Abolished electroretinogram (ERG) (HP:0000550) | 2.76233027 |
| 36 | Cerebral inclusion bodies (HP:0100314) | 2.72657924 |
| 37 | Global brain atrophy (HP:0002283) | 2.71679851 |
| 38 | Retinal atrophy (HP:0001105) | 2.68434600 |
| 39 | Myoglobinuria (HP:0002913) | 2.67358799 |
| 40 | Short phalanx of the thumb (HP:0009660) | 2.66193996 |
| 41 | Vacuolated lymphocytes (HP:0001922) | 2.63721939 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.63624162 |
| 43 | Exercise-induced muscle cramps (HP:0003710) | 2.61083718 |
| 44 | Onion bulb formation (HP:0003383) | 2.60987905 |
| 45 | Supranuclear gaze palsy (HP:0000605) | 2.57208554 |
| 46 | Recurrent bacterial skin infections (HP:0005406) | 2.55851357 |
| 47 | Hemiplegia (HP:0002301) | 2.55831723 |
| 48 | Severe visual impairment (HP:0001141) | 2.55621224 |
| 49 | Loss of speech (HP:0002371) | 2.50810297 |
| 50 | Ketoacidosis (HP:0001993) | 2.47087566 |
| 51 | Hyperventilation (HP:0002883) | 2.43019396 |
| 52 | Progressive cerebellar ataxia (HP:0002073) | 2.40884842 |
| 53 | Prolonged QT interval (HP:0001657) | 2.39991339 |
| 54 | Recurrent abscess formation (HP:0002722) | 2.37845177 |
| 55 | Albinism (HP:0001022) | 2.36904250 |
| 56 | Spondylolisthesis (HP:0003302) | 2.36886801 |
| 57 | Progressive neurologic deterioration (HP:0002344) | 2.36061508 |
| 58 | Axonal loss (HP:0003447) | 2.33891395 |
| 59 | Pigmentary retinal degeneration (HP:0001146) | 2.33697340 |
| 60 | Glomerulonephritis (HP:0000099) | 2.32469844 |
| 61 | Osteomalacia (HP:0002749) | 2.30732418 |
| 62 | Chorioretinal atrophy (HP:0000533) | 2.29054263 |
| 63 | Complement deficiency (HP:0004431) | 2.28326775 |
| 64 | Abnormality of the fovea (HP:0000493) | 2.28102365 |
| 65 | Poikilocytosis (HP:0004447) | 2.27017062 |
| 66 | Febrile seizures (HP:0002373) | 2.26973847 |
| 67 | Abnormality of DNA repair (HP:0003254) | 2.25299455 |
| 68 | Ventricular fibrillation (HP:0001663) | 2.25078421 |
| 69 | Stomatitis (HP:0010280) | 2.24766755 |
| 70 | Ketosis (HP:0001946) | 2.24450859 |
| 71 | Neuronal loss in central nervous system (HP:0002529) | 2.24033719 |
| 72 | Hypoalphalipoproteinemia (HP:0003233) | 2.23882521 |
| 73 | Absent thumb (HP:0009777) | 2.22823678 |
| 74 | Carpal bone hypoplasia (HP:0001498) | 2.21734439 |
| 75 | Tachypnea (HP:0002789) | 2.21625205 |
| 76 | Stenosis of the external auditory canal (HP:0000402) | 2.18469464 |
| 77 | Interstitial pulmonary disease (HP:0006530) | 2.16579662 |
| 78 | Pendular nystagmus (HP:0012043) | 2.15498447 |
| 79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.15052924 |
| 80 | Protruding tongue (HP:0010808) | 2.13358629 |
| 81 | Abnormal EKG (HP:0003115) | 2.13353041 |
| 82 | Status epilepticus (HP:0002133) | 2.12702726 |
| 83 | Visual hallucinations (HP:0002367) | 2.12676635 |
| 84 | Arterial tortuosity (HP:0005116) | 2.12505940 |
| 85 | Truncal ataxia (HP:0002078) | 2.12001563 |
| 86 | Fused cervical vertebrae (HP:0002949) | 2.11776661 |
| 87 | Abnormality of macrophages (HP:0004311) | 2.10730314 |
| 88 | Orchitis (HP:0100796) | 2.09444418 |
| 89 | Tetraparesis (HP:0002273) | 2.09397633 |
| 90 | Short hallux (HP:0010109) | 2.09211418 |
| 91 | Xanthomatosis (HP:0000991) | 2.08696429 |
| 92 | Obstructive sleep apnea (HP:0002870) | 2.08297217 |
| 93 | Upper motor neuron abnormality (HP:0002127) | 2.08234649 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.08096551 |
| 95 | Optic neuritis (HP:0100653) | 2.08096551 |
| 96 | Intestinal fistula (HP:0100819) | 2.07727070 |
| 97 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.07430907 |
| 98 | Hypoplasia of the fovea (HP:0007750) | 2.07430907 |
| 99 | Recurrent fungal infections (HP:0002841) | 2.07387997 |
| 100 | Aplasia/Hypoplasia of the macula (HP:0008059) | 2.05630828 |
| 101 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.05501932 |
| 102 | Myositis (HP:0100614) | 2.03518196 |
| 103 | Thyroiditis (HP:0100646) | 2.03461335 |
| 104 | Macroglossia (HP:0000158) | 2.03203776 |
| 105 | Acanthocytosis (HP:0001927) | 2.02614998 |
| 106 | Colitis (HP:0002583) | 2.02237144 |
| 107 | Paralysis (HP:0003470) | 2.00776234 |
| 108 | Late onset (HP:0003584) | 2.00719994 |
| 109 | Gaze-evoked nystagmus (HP:0000640) | 1.98752966 |
| 110 | Clumsiness (HP:0002312) | 1.98067736 |
| 111 | Hand muscle atrophy (HP:0009130) | 1.97557751 |
| 112 | Tented upper lip vermilion (HP:0010804) | 1.97463054 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.96774711 |
| 114 | Aneurysm (HP:0002617) | 1.96561022 |
| 115 | Leukocytosis (HP:0001974) | 1.96276765 |
| 116 | Macular degeneration (HP:0000608) | 1.96143071 |
| 117 | Restrictive lung disease (HP:0002091) | 1.95759866 |
| 118 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 1.94966563 |
| 119 | Vascular tortuosity (HP:0004948) | 1.94602510 |
| 120 | Ocular albinism (HP:0001107) | 1.94222378 |
| 121 | Hypoplasia of the thymus (HP:0000778) | 1.93988810 |
| 122 | Hypoglycemic coma (HP:0001325) | 1.92844319 |
| 123 | Posterior subcapsular cataract (HP:0007787) | 1.92332577 |
| 124 | Oligomenorrhea (HP:0000876) | 1.91703678 |
| 125 | Hypoplasia of the odontoid process (HP:0003311) | 1.90754727 |
| 126 | Severe muscular hypotonia (HP:0006829) | 1.90255235 |
| 127 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.90156049 |
| 128 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.90156049 |
| 129 | Myocardial infarction (HP:0001658) | 1.89629337 |
| 130 | Type II diabetes mellitus (HP:0005978) | 1.88953353 |
| 131 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.87858856 |
| 132 | Hypoglycemic seizures (HP:0002173) | 1.87857604 |
| 133 | Upper limb amyotrophy (HP:0009129) | 1.87633299 |
| 134 | Distal upper limb amyotrophy (HP:0007149) | 1.87633299 |
| 135 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.87082857 |
| 136 | Stereotypic behavior (HP:0000733) | 1.86336945 |
| 137 | Spontaneous hematomas (HP:0007420) | 1.85877726 |
| 138 | Toxemia of pregnancy (HP:0100603) | 1.85614803 |
| 139 | Impaired smooth pursuit (HP:0007772) | 1.84824784 |
| 140 | Hypochromic microcytic anemia (HP:0004840) | 1.84760049 |
| 141 | Cone-rod dystrophy (HP:0000548) | 1.83823103 |
| 142 | Broad-based gait (HP:0002136) | 1.82321628 |
| 143 | Eczematoid dermatitis (HP:0000976) | 1.81687187 |
| 144 | Hemiparesis (HP:0001269) | 1.79690698 |
| 145 | Broad metatarsal (HP:0001783) | 1.79602438 |
| 146 | Attenuation of retinal blood vessels (HP:0007843) | 1.79499465 |
| 147 | Focal seizures (HP:0007359) | 1.78570133 |
| 148 | Abnormality of the odontoid process (HP:0003310) | 1.77589772 |
| 149 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.77588948 |
| 150 | Hypochromic anemia (HP:0001931) | 1.77291889 |
| 151 | Abnormality of vision evoked potentials (HP:0000649) | 1.75875741 |
| 152 | Skin nodule (HP:0200036) | 1.75367769 |
| 153 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.74466598 |
| 154 | Recurrent cutaneous fungal infections (HP:0011370) | 1.74466598 |
| 155 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.74280801 |
| 156 | Persistence of primary teeth (HP:0006335) | 1.73151152 |
| 157 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.72729231 |
| 158 | Hemoptysis (HP:0002105) | 1.72702863 |
| 159 | Postural instability (HP:0002172) | 1.72290680 |
| 160 | Syncope (HP:0001279) | 1.72131423 |
| 161 | Rectovaginal fistula (HP:0000143) | 1.71511789 |
| 162 | Rectal fistula (HP:0100590) | 1.71511789 |
| 163 | Decreased circulating renin level (HP:0003351) | 1.71114150 |
| 164 | T lymphocytopenia (HP:0005403) | 1.71100014 |
| 165 | Rectal prolapse (HP:0002035) | 1.70789999 |
| 166 | EMG: neuropathic changes (HP:0003445) | 1.70316002 |
| 167 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.70263193 |
| 168 | Difficulty running (HP:0009046) | 1.66967007 |
| 169 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.66965557 |
| 170 | Mutism (HP:0002300) | 1.66664760 |
| 171 | Disinhibition (HP:0000734) | 1.64314947 |
| 172 | Subcapsular cataract (HP:0000523) | 1.64258146 |
| 173 | Mitral stenosis (HP:0001718) | 1.64205512 |
| 174 | Dementia (HP:0000726) | 1.64196347 |
| 175 | Abnormality of proline metabolism (HP:0010907) | 1.63942514 |
| 176 | Hydroxyprolinuria (HP:0003080) | 1.63942514 |
| 177 | Aortic aneurysm (HP:0004942) | 1.63665373 |
| 178 | Fatigue (HP:0012378) | 1.61119185 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 3.51221934 |
| 2 | TAOK3 | 3.19926308 |
| 3 | TRIB3 | 3.17751107 |
| 4 | ERN1 | 3.04909175 |
| 5 | PKN2 | 2.85421379 |
| 6 | FLT3 | 2.64311137 |
| 7 | DAPK2 | 2.56198962 |
| 8 | TGFBR2 | 2.52327237 |
| 9 | MAP3K10 | 2.46027970 |
| 10 | INSRR | 2.29843126 |
| 11 | EEF2K | 2.22114278 |
| 12 | MAP3K13 | 2.21448280 |
| 13 | ADRBK2 | 2.09480479 |
| 14 | BCKDK | 2.08730095 |
| 15 | TTN | 2.07844971 |
| 16 | KIT | 1.89899609 |
| 17 | GRK1 | 1.87900967 |
| 18 | SIK1 | 1.86557933 |
| 19 | ACVR1B | 1.86465474 |
| 20 | CDC42BPA | 1.82253612 |
| 21 | MAP4K1 | 1.78841192 |
| 22 | TYK2 | 1.70799289 |
| 23 | CAMK1D | 1.65334041 |
| 24 | PINK1 | 1.56985613 |
| 25 | JAK3 | 1.55992951 |
| 26 | BLK | 1.55527969 |
| 27 | TBK1 | 1.54151695 |
| 28 | MAP3K11 | 1.51647692 |
| 29 | CSF1R | 1.49991042 |
| 30 | KSR2 | 1.48669646 |
| 31 | MAPK15 | 1.44489831 |
| 32 | NTRK3 | 1.43159403 |
| 33 | PTK6 | 1.32089065 |
| 34 | TXK | 1.27138489 |
| 35 | MAP3K9 | 1.25825038 |
| 36 | HIPK2 | 1.25078090 |
| 37 | MAP3K7 | 1.20945439 |
| 38 | ICK | 1.20803128 |
| 39 | CAMKK1 | 1.20009609 |
| 40 | EPHB1 | 1.19321821 |
| 41 | CAMK1G | 1.17848701 |
| 42 | BRD4 | 1.17064515 |
| 43 | JAK1 | 1.17021587 |
| 44 | PHKG1 | 1.16296980 |
| 45 | PHKG2 | 1.16296980 |
| 46 | PIK3CG | 1.16071586 |
| 47 | MAP2K6 | 1.15299861 |
| 48 | TNK2 | 1.15130608 |
| 49 | SYK | 1.08792617 |
| 50 | AKT3 | 1.08410774 |
| 51 | MAP3K3 | 1.06149548 |
| 52 | SGK2 | 1.06033775 |
| 53 | STK11 | 1.04292437 |
| 54 | JAK2 | 1.04135766 |
| 55 | PRPF4B | 1.03956943 |
| 56 | MAP3K14 | 1.03235834 |
| 57 | PAK6 | 1.02998535 |
| 58 | MAP2K1 | 1.00173677 |
| 59 | TLK1 | 1.00163985 |
| 60 | RIPK1 | 1.00009039 |
| 61 | WNK1 | 0.98083242 |
| 62 | CDK12 | 0.97620759 |
| 63 | NEK1 | 0.96833513 |
| 64 | GRK7 | 0.95301225 |
| 65 | PRKD3 | 0.94698053 |
| 66 | RPS6KA6 | 0.94466632 |
| 67 | SGK494 | 0.93685695 |
| 68 | SGK223 | 0.93685695 |
| 69 | PRKAA2 | 0.92484550 |
| 70 | MAP2K3 | 0.92261458 |
| 71 | BMX | 0.90392409 |
| 72 | EPHA3 | 0.89840787 |
| 73 | RPS6KA2 | 0.89221014 |
| 74 | STK38 | 0.88998841 |
| 75 | CAMK1 | 0.88975672 |
| 76 | MOS | 0.84726725 |
| 77 | DMPK | 0.84406894 |
| 78 | PRKAA1 | 0.83281694 |
| 79 | MAPKAPK3 | 0.82925270 |
| 80 | MARK2 | 0.82284666 |
| 81 | BTK | 0.81852976 |
| 82 | BMPR1B | 0.80792615 |
| 83 | PRKD2 | 0.80707151 |
| 84 | RPS6KL1 | 0.78728057 |
| 85 | RPS6KC1 | 0.78728057 |
| 86 | PTK2B | 0.78652738 |
| 87 | STK10 | 0.78207478 |
| 88 | CAMKK2 | 0.77964168 |
| 89 | IKBKB | 0.77689633 |
| 90 | ZAP70 | 0.76362215 |
| 91 | IRAK3 | 0.76059571 |
| 92 | LMTK2 | 0.75536549 |
| 93 | SCYL2 | 0.75117904 |
| 94 | PRKD1 | 0.74292905 |
| 95 | MAPK7 | 0.73688780 |
| 96 | CLK1 | 0.72190085 |
| 97 | MAPK12 | 0.70780760 |
| 98 | RIPK4 | 0.70694886 |
| 99 | HCK | 0.69238309 |
| 100 | NEK9 | 0.68935348 |
| 101 | LATS1 | 0.68802565 |
| 102 | RAF1 | 0.68659457 |
| 103 | RET | 0.67939370 |
| 104 | MTOR | 0.67266510 |
| 105 | TAOK1 | 0.66706111 |
| 106 | CDK9 | 0.66550275 |
| 107 | TYRO3 | 0.62228528 |
| 108 | MAP3K1 | 0.61583394 |
| 109 | CHUK | 0.61578389 |
| 110 | FGFR4 | 0.60154929 |
| 111 | PTK2 | 0.60140253 |
| 112 | PDK1 | 0.60112791 |
| 113 | ITK | 0.59648842 |
| 114 | CSK | 0.59539485 |
| 115 | GRK6 | 0.58967440 |
| 116 | SGK3 | 0.58937895 |
| 117 | PDGFRB | 0.58613817 |
| 118 | MET | 0.58149498 |
| 119 | LYN | 0.57888149 |
| 120 | MAP2K4 | 0.57808743 |
| 121 | DDR2 | 0.56113586 |
| 122 | FGFR2 | 0.55753940 |
| 123 | PRKCH | 0.55395006 |
| 124 | SIK2 | 0.55201548 |
| 125 | IKBKE | 0.54772356 |
| 126 | FGFR3 | 0.54489975 |
| 127 | SGK1 | 0.54484600 |
| 128 | ADRBK1 | 0.54371306 |
| 129 | FES | 0.54049404 |
| 130 | MAPK11 | 0.52850530 |
| 131 | DYRK1B | 0.51947395 |
| 132 | PDPK1 | 0.51899097 |
| 133 | PAK4 | 0.51712087 |
| 134 | PASK | 0.51018519 |
| 135 | LCK | 0.48788341 |
| 136 | MATK | 0.47207027 |
| 137 | TRPM7 | 0.45245657 |
| 138 | IRAK4 | 0.43417399 |
| 139 | STK4 | 0.41667665 |
| 140 | MAP3K6 | 0.38106858 |
| 141 | CAMK4 | 0.37917286 |
| 142 | OBSCN | 0.37153564 |
| 143 | PAK2 | 0.35485351 |
| 144 | MAP3K2 | 0.35277255 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.33671544 |
| 2 | Lysosome_Homo sapiens_hsa04142 | 2.98717025 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 2.87379402 |
| 4 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 2.46005359 |
| 5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.00974013 |
| 6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.85592629 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.84902535 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.84234302 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.79804155 |
| 10 | Circadian rhythm_Homo sapiens_hsa04710 | 1.74557951 |
| 11 | Lysine degradation_Homo sapiens_hsa00310 | 1.71308075 |
| 12 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.68811842 |
| 13 | ABC transporters_Homo sapiens_hsa02010 | 1.64974986 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.63611303 |
| 15 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.63551147 |
| 16 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.63275995 |
| 17 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.59656777 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.59276791 |
| 19 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.55765722 |
| 20 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.50656607 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46854048 |
| 22 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.43577048 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.39297209 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.37403300 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.36457343 |
| 26 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33506313 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.33451510 |
| 28 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.22778143 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.22669793 |
| 30 | Morphine addiction_Homo sapiens_hsa05032 | 1.17710491 |
| 31 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.16318875 |
| 32 | Phototransduction_Homo sapiens_hsa04744 | 1.13526271 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.13095061 |
| 34 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.12587115 |
| 35 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.10982207 |
| 36 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.10517723 |
| 37 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.10338201 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.08191639 |
| 39 | Circadian entrainment_Homo sapiens_hsa04713 | 1.07253513 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.06162991 |
| 41 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04797980 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.03937997 |
| 43 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.03063563 |
| 44 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.00349822 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.99931286 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99583370 |
| 47 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.99423499 |
| 48 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.98743645 |
| 49 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98718443 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.96372445 |
| 51 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.95475291 |
| 52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.95139519 |
| 53 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.94875568 |
| 54 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.94253450 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91803217 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.91255352 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.91252635 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.91078643 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.90052371 |
| 60 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.89937556 |
| 61 | Nicotine addiction_Homo sapiens_hsa05033 | 0.89837592 |
| 62 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88166640 |
| 63 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.87824246 |
| 64 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.87491817 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.87350180 |
| 66 | Allograft rejection_Homo sapiens_hsa05330 | 0.87202529 |
| 67 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.87149212 |
| 68 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.87093282 |
| 69 | GABAergic synapse_Homo sapiens_hsa04727 | 0.86845077 |
| 70 | Renin secretion_Homo sapiens_hsa04924 | 0.86710878 |
| 71 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86480707 |
| 72 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.86361658 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.86218017 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.85779486 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.84323427 |
| 76 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.83400655 |
| 77 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83083592 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82437359 |
| 79 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.82036328 |
| 80 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.81678866 |
| 81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.81568301 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.81432730 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81142861 |
| 84 | Insulin secretion_Homo sapiens_hsa04911 | 0.81125926 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.80946441 |
| 86 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.80761207 |
| 87 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.80725965 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.79540878 |
| 89 | Asthma_Homo sapiens_hsa05310 | 0.78146002 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76229697 |
| 91 | Salivary secretion_Homo sapiens_hsa04970 | 0.75657604 |
| 92 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.75355868 |
| 93 | Leishmaniasis_Homo sapiens_hsa05140 | 0.75283647 |
| 94 | Prion diseases_Homo sapiens_hsa05020 | 0.74281865 |
| 95 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.73918395 |
| 96 | Mineral absorption_Homo sapiens_hsa04978 | 0.73197406 |
| 97 | Bile secretion_Homo sapiens_hsa04976 | 0.72926823 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72727106 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71909526 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.70945741 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70734417 |
| 102 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.70450556 |
| 103 | Peroxisome_Homo sapiens_hsa04146 | 0.70331175 |
| 104 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.70010696 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69640558 |
| 106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68777060 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.68579168 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.67675688 |
| 109 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67580307 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67394112 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.67062077 |
| 112 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.66602545 |
| 113 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66241555 |
| 114 | Tuberculosis_Homo sapiens_hsa05152 | 0.65704608 |
| 115 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.64837224 |
| 116 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64700694 |
| 117 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64069573 |
| 118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63935847 |
| 119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.62546108 |
| 120 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.61328881 |
| 121 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61277680 |
| 122 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.60791173 |
| 123 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60580802 |
| 124 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.60255678 |
| 125 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.60120360 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59783006 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.58604107 |
| 128 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58554256 |
| 129 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58425118 |
| 130 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.58322295 |
| 131 | Long-term depression_Homo sapiens_hsa04730 | 0.58108136 |
| 132 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57767168 |
| 133 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.55504761 |
| 134 | Hepatitis C_Homo sapiens_hsa05160 | 0.54988587 |
| 135 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54264802 |
| 136 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.53465585 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52292500 |
| 138 | Apoptosis_Homo sapiens_hsa04210 | 0.52040615 |
| 139 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.49992151 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49374266 |
| 141 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.49284612 |
| 142 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47932534 |
| 143 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.47510774 |
| 144 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47247536 |
| 145 | Sulfur relay system_Homo sapiens_hsa04122 | 0.46790894 |
| 146 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.46492617 |
| 147 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.45563058 |
| 148 | Legionellosis_Homo sapiens_hsa05134 | 0.44716381 |
| 149 | Measles_Homo sapiens_hsa05162 | 0.43818353 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43677694 |
| 151 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43240507 |
| 152 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.43091842 |
| 153 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.42400874 |
| 154 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41058858 |
| 155 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.40985210 |
| 156 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.39675087 |
| 157 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.38819787 |
| 158 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38590614 |
| 159 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.38074818 |

